Non-small cell lung cancer - initial authority application form (PB156)

Use this form to apply for initial PBS-subsidised treatment with crizotinib, entrectinib or repotrectinib for Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer.

Page last updated: 2 April 2026.
QC 21131